In a filing, Praxis Precision Medicines Inc revealed its General Counsel and Secretary Nemiroff Alex unloaded Company’s shares for reported $0.66 million on Nov 14 ’24. In the deal valued at $80.20 per share,8,239 shares were sold. As a result of this transaction, Nemiroff Alex now holds 10,301 shares worth roughly $0.65 million.
Then, Mastrocola Lauren sold 5,188 shares, generating $424,318 in total proceeds. Upon selling the shares at $81.78, the Principal Accounting Officer now owns 5,613 shares.
Before that, Mastrocola Lauren bought 5,189 shares. Praxis Precision Medicines Inc shares valued at $424,316 were divested by the Officer at a price of $81.77 per share.
Oppenheimer initiated its Praxis Precision Medicines Inc [PRAX] rating to an Outperform in a research note published on August 05, 2024; the price target was $134. A number of analysts have revised their coverage, including Needham’s analysts, who began to cover the stock in late June with a ‘”a Buy”‘ rating. Guggenheim began covering PRAX with “Buy” recommendation on June 18, 2024. Robert W. Baird started covering the stock on May 01, 2024. It rated PRAX as “an Outperform”.
Price Performance Review of PRAX
On Friday, Praxis Precision Medicines Inc [NASDAQ:PRAX] saw its stock fall -14.29% to $63.15. Over the last five days, the stock has lost -20.59%. Praxis Precision Medicines Inc shares have fallen nearly -17.94% since the year began. Nevertheless, the stocks have risen 60.69% over the past one year. While a 52-week high of $86.93 was reached on 01/06/25, a 52-week low of $31.26 was recorded on 01/10/25. SMA at 50 days reached $74.42, while 200 days put it at $58.50.
Levels Of Support And Resistance For PRAX Stock
The 24-hour chart illustrates a support level at 59.75, which if violated will result in even more drops to 56.36. On the upside, there is a resistance level at 69.53. A further resistance level may holdings at 75.92. The Relative Strength Index (RSI) on the 14-day chart is 33.57, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -4.67, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 97.80%. Stochastics %K at 27.77% indicates the stock is a holding.
How much short interest is there in Praxis Precision Medicines Inc?
A steep rise in short interest was recorded in Praxis Precision Medicines Inc stocks on 2024-12-13, growing by 4736.0 shares to a total of 1.53 million shares. Yahoo Finance data shows the prior-month short interest on 2024-11-15 was 1.53 million shares. There was a rise of 0.31%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on September 19, 2023 when Truist began covering the stock and recommended ‘”a Buy”‘ rating along with a $10 price target.
